Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Oncotarget
|
December 13, 2017
Ultrasensitive plasma ctDNA <i>KRAS</i> assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma
Inna Chen, Victoria M Raymond, Jennifer A Geis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2013
Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence
Yi Zhang, Catherine A Schnabel, Brock E Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2012
Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier
Sarah E Kerr, Catherine A Schnabel, Peggy S Sullivan, et al.
The Lancet. Oncology
|
September 17, 2013
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
Dennis C Sgroi, Ivana Sestak, Jack Cuzick, et al.
Journal of Lower Genital Tract Disease
|
December 23, 2017
High-Risk Human Papillomavirus Detection in Urine Samples From a Referral Population With Cervical Biopsy-Proven High-Grade Lesions
Adriana T Lorenzi, José Humberto T Fregnani, Janel Dockter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 28, 2013
Development and validation of a 32-gene prognostic index for prostate cancer progression
Chin-Lee Wu, Brock E Schroeder, Xiao-Jun Ma, et al.
Brain Research
|
June 29, 2002
Nuclei and subnuclei gene expression profiling in mammalian brain
Pascal Bonaventure, Hongqing Guo, Bin Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2017
Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine
Hatim Husain, Vladislava O Melnikova, Karena Kosco, et al.
Breast Cancer Research and Treatment
|
October 24, 2018
Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score
Piiha-Lotta Jerevall, Jane Brock, Juan Palazzo, et al.
Oncotarget
|
July 9, 2014
BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease
Filip Janku, Cecile Rose T Vibat, Karena Kosco, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Oncotarget
|
December 13, 2017
Ultrasensitive plasma ctDNA <i>KRAS</i> assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma
Inna Chen, Victoria M Raymond, Jennifer A Geis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2013
Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence
Yi Zhang, Catherine A Schnabel, Brock E Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2012
Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier
Sarah E Kerr, Catherine A Schnabel, Peggy S Sullivan, et al.
The Lancet. Oncology
|
September 17, 2013
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
Dennis C Sgroi, Ivana Sestak, Jack Cuzick, et al.
Journal of Lower Genital Tract Disease
|
December 23, 2017
High-Risk Human Papillomavirus Detection in Urine Samples From a Referral Population With Cervical Biopsy-Proven High-Grade Lesions
Adriana T Lorenzi, José Humberto T Fregnani, Janel Dockter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 28, 2013
Development and validation of a 32-gene prognostic index for prostate cancer progression
Chin-Lee Wu, Brock E Schroeder, Xiao-Jun Ma, et al.
Brain Research
|
June 29, 2002
Nuclei and subnuclei gene expression profiling in mammalian brain
Pascal Bonaventure, Hongqing Guo, Bin Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2017
Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine
Hatim Husain, Vladislava O Melnikova, Karena Kosco, et al.
Breast Cancer Research and Treatment
|
October 24, 2018
Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score
Piiha-Lotta Jerevall, Jane Brock, Juan Palazzo, et al.
Oncotarget
|
July 9, 2014
BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease
Filip Janku, Cecile Rose T Vibat, Karena Kosco, et al.
Page
of 5